Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 4.33B | 3.48B | 2.50B | 2.35B | 2.20B | 2.22B |
Gross Profit | 1.57B | 1.22B | 892.42M | 887.06M | 770.04M | 745.74M |
EBITDA | 604.50M | 430.11M | 225.43M | 288.13M | 313.46M | 342.83M |
Net Income | 414.37M | 275.08M | 133.49M | 175.83M | 206.17M | 221.98M |
Balance Sheet | ||||||
Total Assets | 3.69B | 3.56B | 2.92B | 2.86B | 2.65B | 2.44B |
Cash, Cash Equivalents and Short-Term Investments | 1.60B | 1.77B | 1.92B | 2.06B | 2.05B | 1.79B |
Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 632.00K | 1.64M |
Total Liabilities | 1.06B | 1.08B | 611.43M | 559.44M | 527.98M | 545.70M |
Stockholders Equity | 2.62B | 2.45B | 2.28B | 2.27B | 2.10B | 1.87B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 294.54M | 204.25M | 156.92M | 252.27M | 203.04M |
Operating Cash Flow | 0.00 | 355.54M | 248.28M | 206.78M | 257.37M | 220.57M |
Investing Cash Flow | 0.00 | 170.60M | -459.60M | -136.53M | -219.79M | -214.71M |
Financing Cash Flow | 0.00 | -272.68M | -128.86M | -58.00M | 14.12M | -39.92M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥5.53B | 11.87 | 1.13% | 55.69% | 181.08% | ||
61 Neutral | $35.55B | 8.91 | -10.55% | 1.87% | 8.47% | -8.26% | |
― | €27.29M | 10.57 | 8.20% | ― | ― | ― | |
― | €23.42M | ― | -174.79% | ― | ― | ― | |
― | ¥4.67B | 7.46 | 2.36% | ― | ― | ||
77 Outperform | ¥7.59B | 26.07 | 0.46% | 10.95% | 39.53% | ||
70 Outperform | ¥5.23B | 19.79 | 1.76% | 14.08% | 31.61% |
WITZ Corporation reported significant growth in its financial performance for the six months ending February 28, 2025, with net sales increasing by 57.2% and profit attributable to owners of the parent rising by 162.3% compared to the previous year. The company also maintained a strong equity ratio of 71.1% and announced a forecasted increase in annual dividends per share, reflecting its robust financial health and positive outlook for the fiscal year ending August 31, 2025.